Allogeneic Stem Cell Transplantation of CordIn, Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients with Hemoglobinopathies

Trial Profile

Allogeneic Stem Cell Transplantation of CordIn, Umbilical Cord Blood-Derived Ex Vivo Expanded Stem and Progenitor Cells, in Patients with Hemoglobinopathies

Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 27 May 2017

At a glance

  • Drugs Cord blood stem cell therapy (Primary)
  • Indications Sickle cell anaemia; Thalassaemia
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Gamida-Cell
  • Most Recent Events

    • 16 Jul 2015 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top